Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Wyeth
Headquarters: Madison, NJ, United States of America
Website: N/A
Year Founded: 1926
Status: Acquired
BioCentury | Sep 16, 2024
Management Tracks
AZ veteran Pangalos joining Stampacchia’s Omega Funds
R&D leader will arrive at venture firm next month
BioCentury | Jul 10, 2024
Management Tracks
Pfizer seeking successor as Dolsten prepares to step down from R&D role
Plus: Lexicon, Pathios and Xeris name new CEOs, and updates from Jazz, AgomAb, VectorY, eTheRNA and more
BioCentury | May 22, 2023
Management Tracks
Ning Zhao, WuXi co-founder and philanthropist, passes away
Scientist, executive helped shape WuXi AppTec, WuXi Biologics
BioCentury | Feb 7, 2023
BioCentury Commentary
Big thinkers
Pharma mega-mergers — a look back at the rationale behind the Glaxo-SmithKline tie-up: BioCentury’s 30th anniversary collection
BioCentury | Feb 7, 2023
Management Tracks
Okamura to lead Astellas
Plus: Myers at the helm of Viridian, and updates from Novartis,
BioCentury | Aug 24, 2022
Management Tracks
Bluebird’s Eggimann joins Tessera team
Plus new board appointments at GSK and Alnylam, and updates from Zealand, Pharus and more
BioCentury | Jun 30, 2022
Politics, Policy & Law
Abortion politics could define Califf’s tenure
FDA’s relationship with Congress will be contentious if Republicans win majorities in November
BioCentury | Jun 14, 2022
Product Development
Poxvirus agents, by the mechanisms
The mechanisms of products approved for monkeypox and other orthopoxviruses offer the potential for combinations
BioCentury | Jun 2, 2022
Management Tracks
Anderson to lead Pfizer’s vaccine R&D
Plus CFO Luca Scavo resigns from Evelo, Passage Bio’s CEO steps down, and updates from MindMaze, Black Diamond and more
BioCentury | Apr 15, 2022
Politics, Policy & Law
Congressional spotlight on McKinsey over COI could reach pharmas
Documents raise questions about McKinsey’s work for FDA, life sciences clients
Items per page:
1 - 10 of 2273